News
Ex-Novartis CMO John Tsai pops up at Forcefield
Novartis’ former chief medical officer John Tsai has returned to a …
19804 items found
News
Ionis preps filings for olezarsen in rare disease FCS
Ionis Pharma is preparing to file for regulatory approval of its …
R&D
Partner Content
3rd mRNA-Based Therapeutics Summit Europe
250+ mRNA Specialists | 40+ World-Class Speakers | 2 Streams of …
News
NICE turns down Enhertu in “devastating” move, says charity
AstraZeneca and Daiichi Sankyo’s Enhertu should not be made available …
Digital
Five strategies for delivering digital that makes a difference
Digital innovation has the power to transform healthcare, but there …
News
Alfasigma reaches deal to buy Intercept for $800m
After two FDA rejections for non-alcoholic steatohepatitis (NASH) …
Digital
News
AscellaHealth recognised for rare disease funding programme
AscellaHealth has been given an industry award for a financial …
Digital
News
Takeda joins PIKfyve ALS push with AcuraStem deal
Takeda has bolstered its neuroscience pipeline by licensing drug …
Sales & Marketing
Inside the Inflation Reduction Act’s upcoming legal battles
Nine plaintiffs – six pharma companies and two alliances of industry …
News
Lack of lung disease testing causing ‘avoidable harm’ in NHS
A patient organisation in the UK has said that a lack of basic …
R&D
Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal...
Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Patients
Deep Dive: Patients & Partnerships 2024
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Sales & Marketing
Sponsored
Seeking a single source of truth: Standardisation of the dat...
Oskar Mӧbert, Vice President of OpenData at Veeva Systems, spoke with Ian Cornish, Associate Director of Data Platforms at Astellas, about the company’s decision to opt into Veeva’s OpenDat
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
EHS&S for Biopharma & Pharma Summit
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
